Ruxolitinib (Jakavi®)

External Links

  • Traffic Light
    Red
  • BNF
    8.1.5
  • Licensed Indicators
    Myelofibrosis, either primary in origin or following other related disorders such as polycythaemia
  • Reference
    APC Dec 12
  • Provisional
    Yes

Do you want to add this to your CPD record?

Did you find this page helpful?